1
|
Wright JR, Ly TT, Cromwell KB, Brislawn CJ, Chen See JR, Anderson SLC, Pellegrino J, Peachey L, Walls CY, Lloyd CM, Jones OY, Lawrence MW, Bess JA, Wall AC, Shope AJ, Lamendella R. Assessment of a novel continuous cleaning device using metatranscriptomics in diverse hospital environments. FRONTIERS IN MEDICAL TECHNOLOGY 2023; 5:1015507. [PMID: 36935775 PMCID: PMC10020724 DOI: 10.3389/fmedt.2023.1015507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2022] [Accepted: 02/17/2023] [Indexed: 03/06/2023] Open
Abstract
Introduction Despite routine implementation of cleaning and disinfection practices in clinical healthcare settings, high-touch environmental surfaces and contaminated equipment often serve as reservoirs for the transmission of pathogens associated with healthcare-associated infections (HAIs). Methods The current study involved the analysis of high-touch surface swabs using a metatranscriptomic sequencing workflow (CSI-Dx™) to assess the efficacy of cleanSURFACES® technology in decreasing microbial burden by limiting re-contamination. This is a non-human single center study conducted in the Emergency Department (ED) and on an inpatient Oncology Ward of Walter Reed National Military Medical Center that have followed hygienic practices during the COVID-19 pandemic environment. Results Although there was no difference in observed microbial richness (two-tailed Wilcoxon test with Holm correction, P > 0.05), beta diversity findings identified shifts in microbial community structure between surfaces from baseline and post-intervention timepoints (Day 1, Day 7, Day 14, and Day 28). Biomarker and regression analyses identified significant reductions in annotated transcripts for various clinically relevant microorganisms' post-intervention, coagulase-negative staphylococci and Malassezia restricta, at ED and Oncology ward, respectively. Additionally, post-intervention samples predominantly consisted of Proteobacteria and to a lesser extent skin commensals and endogenous environmental microorganisms in both departments. Discussion Findings support the value of cleanSURFACES®, when coupled with routine disinfection practices, to effectively impact on the composition of active microbial communities found on high-touch surfaces in two different patient care areas of the hospital (one outpatient and one inpatient) with unique demands and patient-centered practices.
Collapse
Affiliation(s)
- Justin R Wright
- Contamination Source Identification, LLC., Huntingdon, PA, United States
| | - Truc T Ly
- Contamination Source Identification, LLC., Huntingdon, PA, United States
| | - Karen B Cromwell
- Walter Reed National Military Medical Center, Bethesda, MD, United States
| | - Colin J Brislawn
- Contamination Source Identification, LLC., Huntingdon, PA, United States
| | - Jeremy R Chen See
- Contamination Source Identification, LLC., Huntingdon, PA, United States
| | | | - Jordan Pellegrino
- Contamination Source Identification, LLC., Huntingdon, PA, United States
| | - Logan Peachey
- Contamination Source Identification, LLC., Huntingdon, PA, United States
| | - Christine Y Walls
- Contamination Source Identification, LLC., Huntingdon, PA, United States
| | - Charise M Lloyd
- Walter Reed National Military Medical Center, Bethesda, MD, United States
| | - Olcay Y Jones
- Walter Reed National Military Medical Center, Bethesda, MD, United States
| | - Matthew W Lawrence
- Walter Reed National Military Medical Center, Bethesda, MD, United States
| | | | | | - Alexander J Shope
- Contamination Source Identification, LLC., Huntingdon, PA, United States
- AIONX, Hershey, PA, United States
| | - Regina Lamendella
- Contamination Source Identification, LLC., Huntingdon, PA, United States
- Correspondence: Regina Lamendella
| |
Collapse
|
2
|
Wright JR, Ly TT, Brislawn CJ, Chen See JR, Anderson SLC, Pellegrino JT, Peachey L, Walls CY, Bess JA, Bailey AL, Braun KE, Shope AJ, Lamendella R. cleanSURFACES® intervention reduces microbial activity on surfaces in a senior care facility. Front Cell Infect Microbiol 2022; 12:1040047. [PMID: 36439229 PMCID: PMC9682068 DOI: 10.3389/fcimb.2022.1040047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Accepted: 10/19/2022] [Indexed: 11/11/2022] Open
Abstract
As one of the top public health challenges outlined by the Centers for Disease Control (CDC), estimates report that hospital acquired infections (HAIs) claim the lives of 99,000 Americans and cost healthcare providers over $28 billion each year. In addition to underlying conditions related to age, elderly patients in long-term care facilities are at an elevated risk of acquiring HAIs. A large percentage of HAIs is attributable to contaminated surfaces and medical devices. To that end, this study utilized a metatranscriptomic sequencing workflow (CSI-Dx™) to profile active microbial communities from surfaces in the HJ Heinz Community Living Center, a long-term care facility in the Veterans Affairs Pittsburgh Health Care System. Swabs were collected from high-touch surfaces (Keyboard, Ledge, Workstation on Wheels, Worksurfaces) before (Baseline) and after cleanSURFACES® were installed at 4 timepoints (Day 1, Day 7, Day 14, and Day 30). Microbial richness was significantly reduced after cleanSURFACES® intervention (Wilcoxon test with Holm correction, p=0.000179). Beta diversity results revealed distinct clustering between Baseline and Post-intervention samples (Adonis, p<0.001). Reduction in bacterial (Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus hominis) and fungal (Malassezia restricta, Candida albicans, Candida glabrata, and Candida orthopsilosis) expression of opportunistic pathogens was observed. Additionally, a subset of taxa (Corynebacterium, Cutibacterium acnes, and Ralstonia pickettii) was present in specific Post-intervention timepoints and surface types. This study revealed decreased microbial activity, highlighting the potential for the combinatorial application of cleanSURFACES® and regular decontamination practices to reduce the prevalence of microbes causing HAIs.
Collapse
|
3
|
Ianiri G, LeibundGut-Landmann S, Dawson TL. Malassezia: A Commensal, Pathogen, and Mutualist of Human and Animal Skin. Annu Rev Microbiol 2022; 76:757-782. [PMID: 36075093 DOI: 10.1146/annurev-micro-040820-010114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Identified in the late nineteenth century as a single species residing on human skin, Malassezia is now recognized as a diverse genus comprising 18 species inhabiting not only skin but human gut, hospital environments, and even deep-sea sponges. All cultivated Malassezia species are lipid dependent, having lost genes for lipid synthesis and carbohydrate metabolism. The surging interest in Malassezia results from development of tools to improve sampling, culture, identification, and genetic engineering, which has led to findings implicating it in numerous skin diseases, Crohn disease, and pancreatic cancer. However, it has become clear that Malassezia plays a multifaceted role in human health, with mutualistic activity in atopic dermatitis and a preventive effect against other skin infections due to its potential to compete with skin pathogens such as Candida auris. Improved understanding of complex microbe-microbe and host-microbe interactions will be required to define Malassezia's role in human and animal health and disease so as to design targeted interventions.
Collapse
Affiliation(s)
- Giuseppe Ianiri
- Department of Agricultural, Environmental, and Food Sciences, University of Molise, Campobasso, Italy
| | - Salomé LeibundGut-Landmann
- Section of Immunology, Faculty of Vetsuisse, and Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland
| | - Thomas L Dawson
- Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore; .,Department of Drug Discovery, College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, USA
| |
Collapse
|